Over 40% of transgender, nonbinary, and gender diverse (TGD) young adults screened positive for depression on the PHQ‑2 in a ...

Depression and anxiety have been well documented in people with multiple sclerosis (MS), but often are undiagnosed or ...

Gender-affirming hormone therapy was associated with a significant reduction in moderate to severe depression among TGD adults in the US.

The Patient Health Questionnaire (PHQ) was used to assess symptoms of moderate to severe depressive symptoms in the previous 2 weeks ... for moderate to severe depression was higher in transgender ...